Mavenclad 10 mg 1 tablet

9980.15

Out of Stock

Product description

Product description: Mavenclad contains the active substance cladribine, which is a cytotoxic (cell-killing) substance that primarily works on lymphocytes, which are immune system cells involved in inflammation. Mavenclad is a medicine used to treat multiple sclerosis (MS) in adults. Multiple sclerosis is a disease in which inflammation leads to destruction of the protective layer around nerves. It has been proven that treatment with Mavenclad reduces the frequency of relapses and slows disease progression. Usage instructions: Always use this medicine exactly as your doctor has told you. Contact your doctor or pharmacist if you are not sure. Treatment courses: You will receive MAVENCLAD as two treatment courses over two years. Each treatment course consists of two weeks of treatment, with a one-month gap at the beginning of each treatment year. The treatment week consists of 4 or 5 days where you receive one or two tablets daily. Your doctor will perform a blood test before starting the treatment course to ensure that your lymphocyte level (a type of white blood cell) is within the acceptable range. If not, your treatment may be delayed. Once two treatment courses are completed over two years, your doctor will continue to monitor your health for another two years, during which you will not need to take the medicine. Dosage: You will be prescribed the correct number of tablets for each week of treatment based on your body weight. You will need one or more boxes to get the correct number of tablets. When you receive your medication, you should verify that you have received the correct number of tablets. In the left column of the table below, find the row that matches your body weight (in kilograms) and check the number of tablets that should be in the package(s) for the upcoming treatment week. If the number of tablets in the package(s) does not match the number indicated for your weight in the table below, you should consult your doctor. Note that for some weight ranges, the number of tablets may vary from week to week. How to use the medicine: Take the tablet(s) at approximately the same time each day. Swallow them with water without chewing. You do not need to take the tablets with food. You can take them with or without a meal. Duration of the treatment week: Depending on the total number of tablets prescribed for you, you should take them over 4 or 5 days each treatment week. If you take too much Mavenclad: If you take more tablets than prescribed, you should contact your doctor immediately. Your doctor will decide whether you need to stop treatment. There is limited experience with overdose of Mavenclad. It is known that the more medication you take, the fewer lymphocytes you have in your body, which can lead to lymphocyte disease. If you miss two consecutive days (for example, the dose on day 3 and day 4), take the missed dose(s) on the following two days, then extend the treatment week by two days. Ask your doctor or pharmacist if you have any questions about using this medicine. Warnings and precautions: Do not use Mavenclad: if you are allergic to the drug cladribine or any other ingredients of this medicine. if you have active tuberculosis or hepatitis (hepatitis). if you have a weakened immune system due to medical conditions or because you are taking other medicines that weaken your immune system or reduce blood cell production in the bone marrow. These include: cyclosporine, cyclophosphamide, azathioprine (used to suppress the immune system, for example after organ transplantation), methotrexate (used to treat conditions like psoriasis or rheumatoid arthritis), long-term use of corticosteroids (used to reduce inflammation, for example in asthma). if you have active cancer. if you have moderate or severe kidney problems. if you are pregnant or breastfeeding (see also "Pregnancy and breastfeeding"). Do not use Mavenclad and contact your doctor or pharmacist if you are unsure whether any of the above conditions apply to you. Children and adolescents: Mavenclad is not recommended for patients under 18 years old, as it has not been studied in this age group. Other medicines and MAVENCLAD: Talk to your doctor or pharmacist if you are using, have recently used, or plan to use other medicines. Do not start Mavenclad with medicines that weaken the immune system or reduce blood cell production in the bone marrow. These include: cyclosporine, cyclophosphamide, azathioprine (used to suppress the immune system, for example after organ transplantation), methotrexate (used for conditions like psoriasis or rheumatoid arthritis). Long-term use of corticosteroids (used to reduce inflammation, for example in asthma) can be used short-term when your doctor says so. Mavenclad should not be used with other multiple sclerosis medicines unless explicitly recommended by your doctor. Pregnancy and breastfeeding: Do not use Mavenclad if you are pregnant or trying to conceive. This is important because Mavenclad can harm your unborn baby. You should use effective contraception to avoid pregnancy during treatment with Mavenclad and for 6 months after the last dose. Talk to your doctor if you are taking hormonal contraceptives (like "birth control pills"). You need an additional method of contraception during treatment and for at least 4 weeks after the last dose. If you become pregnant within 6 months of the last dose in the first year, safety risks are not expected, but this means you cannot receive treatment with Mavenclad during pregnancy. Men should use safe methods of contraception to prevent their partner from becoming pregnant during your treatment with MAVENCLAD and for 6 months after the last dose. Your doctor will give you guidance on suitable contraception methods. Do not use Mavenclad if you are breastfeeding. If your doctor considers Mavenclad important for you, they will ask you to stop breastfeeding during treatment and for at least one week after the last dose. Driving and operating machinery: Mavenclad is not expected to affect the ability to drive or operate machinery. Ingredients: Cladribine 10 mg Product details: Brand: Mavenclad Product model: Tablets

Questions you might have

‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌
‌
‌‌
‌